Quarter | Holdings | Value ($000) | Top Holdings | Form Type | Date Filed | Filing ID |
---|---|---|---|---|---|---|
Q3 2024 | 3 | 20,119 | CGON, RPID, LUNG | 13F-HR | 11/14/2024 | 000095012324011466 |
Q2 2024 | 3 | 29,969 | CGON, RPID, LUNG | 13F-HR | 8/14/2024 | 000095012324008423 |
Q1 2024 | 3 | 41,516 | CG ONCOLOGY INC, RPID, LUNG | 13F-HR | 5/15/2024 | 000095012324005234 |
Q4 2023 | 4 | 51,311 | RYZB, MDVL, RPID, LUNG | 13F-HR | 2/14/2024 | 000095012324002155 |
Q3 2023 | 4 | 20,838 | RYZB, MDVL, RPID, LUNG | 13F-HR | 11/14/2023 | 000095012323010777 |
Q2 2023 | 3 | 5,511 | MDVL, RPID, LUNG | 13F-HR | 8/14/2023 | 000095012323008200 |
Q1 2023 | 3 | 6,340 | MDVL, RPID, LUNG | 13F-HR | 5/15/2023 | 000095012323004993 |
Q4 2022 | 3 | 6,186 | MDVL, RPID, LUNG | 13F-HR | 2/14/2023 | 000095012323002333 |
Q3 2022 | 3 | 16,020 | MDVL, RPID, LUNG | 13F-HR | 11/14/2022 | 000095012322011723 |
Q2 2022 | 3 | 28,346 | MDVL, RPID, LUNG | 13F-HR | 8/15/2022 | 000095012322009125 |
Q1 2022 | 3 | 12,318 | RPID, MDVL, LUNG | 13F-HR | 5/16/2022 | 000095012322005952 |
Q4 2021 | 2 | 7,371 | MDVL, LUNG | 13F-HR | 2/14/2022 | 000095012322002415 |
Q3 2021 | 2 | 14,723 | MDVL, LUNG | 13F-HR | 11/15/2021 | 000095012321015121 |
Q2 2021 | 2 | 51,743 | MDVL, LUNG | 13F-HR | 8/16/2021 | 000095012321011104 |
Q1 2021 | 2 | 91,682 | MDVL, LUNG | 13F-HR | 5/17/2021 | 000095012321006751 |
Q4 2020 | 2 | 114,737 | MDVL, LUNG | 13F-HR | 2/16/2021 | 000095012321002369 |